CoChat

Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement

Open access

The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index; 21 of the 83 sources its claims cite were checked for support.

Abstract

Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in individuals with obesity due to metabolic changes associated with a sedentary lifestyle, adipose tissue derangements, comorbidities (acute and chronic diseases) and during the ageing process. Co-existence of excess adiposity and low muscle mass/function is referred to as sarcopenic obesity (SO), a condition increasingly recognized for its clinical and functional features that negatively influence important patient-centred outcomes. Effective prevention and treatment strategies for SO are urgently needed, but efforts are hampered by the lack of a universally established SO definition and diagnostic criteria. Resulting inconsistencies in the literature also negatively affect the ability to define prevalence as well as clinical relevance of SO for negative health outcomes. Aims and Methods: The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched an initiative to reach expert consensus on a definition and diagnostic criteria for SO. The jointly appointed international expert panel proposes that SO is defined as the co-existence of excess adiposity and low muscle mass/function. The diagnosis of SO should be considered in at-risk individuals who screen positive for a co-occurring elevated body mass index or waist circumference, and markers of low skeletal muscle mass and function (risk factors, clinical symptoms, or validated questionnaires). Diagnostic procedures should initially include assessment of skeletal muscle function, followed by assessment of body composition where presence of excess adiposity and low skeletal muscle mass or related body compartments confirm the diagnosis of SO. Individuals with SO should be further stratified into stage I in the absence of clinical complications or stage II if cases are associated with complications linked to altered body composition or skeletal muscle dysfunction. Conclusions: ESPEN and EASO, as well as the expert international panel, advocate that the proposed SO definition and diagnostic criteria be implemented into routine clinical practice. The panel also encourages prospective studies in addition to secondary analysis of existing data sets, to study the predictive value, treatment efficacy and clinical impact of this SO definition.

Overview

CoChat Summary

TL;DR

This ESPEN/EASO consensus statement defines sarcopenic obesity (SO) as the co-existence of excess adiposity and low muscle mass/function and proposes a screening, diagnosis, and staging algorithm. After a four-phase Delphi process, the expert panel reached 93.6% agreement on the global proposal.

Key findings

  • SO is defined as the co-existence of obesity and sarcopenia: obesity as high body fat percentage, and sarcopenia as low skeletal muscle mass accompanied by low muscle function. Diagnosis requires both altered skeletal muscle functional parameters and altered body composition after positive screening.
  • Screening uses elevated BMI or waist circumference with ethnicity-specific cut points plus surrogate indicators/risk factors or validated questionnaires (e.g., SARC-F in older subjects); all people with obesity/overweight above age 70 are considered at risk of SO.
  • Diagnostic sequence: assess skeletal muscle function first (e.g., hand-grip strength, knee extensor strength, chair-stand test), then body composition by DXA or BIA as second choice, with CT when possible. The panel suggests cut points from Dodds et al. and Chen et al. for HGS, Gallagher et al. for FM, Janssen et al. for SMM/W, and Batsis et al. for ALM/W. Staging is Stage I (no complications) or Stage II (at least one complication attributable to altered body composition and skeletal muscle functional parameters).
  • The background systematic review found unified fat-plus-muscle parameters in only 6 of 75 selected studies; 28 of 75 studies had a mean age below 65 years. In a sample of 727 participants with obesity, SO prevalence was 34.8% in males and 50.1% in females; in another sample of 147 individuals with obesity, 63.3% met criteria for reduced lean mass. Proposed upper sex-specific body fat cut-offs were 40% for females and 30% for males.

Methods

  • ESPEN and EASO launched a consensus initiative following standard operating procedures for ESPEN guidelines and consensus papers. A pool of 38 international researchers from 16 countries on four continents contributed, with five members coordinating.
  • The consensus procedure used a four-phase Delphi process with sequential web-based questionnaires (rounds in 2020–2021). Participants ranked statements on a 5-point Likert scale, and statements with >75% positive responses (agree or strongly agree) advanced.
  • After four rounds, the global proposal encompassing SO definition, screening, diagnosis, and staging reached 93.6% agreement (agree + strongly agree).

Limitations

  • Stated: the statements are expert-based rather than necessarily evidence-based; the group was self-appointed, initiated by ESPEN and EASO representatives with subsequent expert panel selection. Lack of consistency in prior operational criteria may affect any consensus initiative.
  • Stated: the staging proposal has not been investigated and is based entirely on clinical expert opinion. No universally accepted validated references are available for most parameters; it remains unclear whether T scores or Z scores should be used, and cut-offs need validation against specific adverse outcomes.
  • Evident from the text: the proposed algorithm and staging are not empirically tested in this paper, and many cited cut-offs come from heterogeneous populations by age, sex, and ethnicity, with most studies in Caucasian groups, limiting generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1159/000521241

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 3 Not valid · 34 Not checked · 37 Own results and interpretations

37 more claims · 2 with their cited sources checked

Create a free account to see all 85 claims and to verify the 62 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 26

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

9 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. 10.1007/s10522-015-9626-484 · doi:10.1007/s10522-015-9626-484

Cited by

See all 1,019

Metadata

Authors
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., Frara, S., Frühbeck, G., Genton, L., Gepner, Y., Giustina, A., Gonzalez, M. C., Han, H.-S., Heymsfield, S. B., Higashiguchi, T., Laviano, A., Lenzi, A., Nyulasi, I., Parrinello, E., Poggiogalle, E., Prado, C. M., Salvador, J., Rolland, Y., Santini, F., Serlie, M. J., Shi, H., Sieber, C. C., Siervo, M., Vettor, R., Villareal, D. T., Volkert, D., Yu, J., Zamboni, M., & Barazzoni, R.
Affiliations
  • Sapienza University of Rome (IT)
  • University of Padua (IT)
  • University of Hohenheim (DE)
  • Uppsala University (SE)
  • University of North Carolina at Chapel Hill (US)
  • Heidelberg University (DE)
  • Instituto Ramón y Cajal de Investigación Sanitaria (ES)
  • Tel Aviv University (IL)
  • Vita-Salute San Raffaele University (IT)
  • Clinica Universidad de Navarra (ES)
  • University Hospital of Geneva (CH)
  • Seoul National University Bundang Hospital (KR)
  • Pennington Biomedical Research Center (US)
  • Fujita Health University (JP)
  • Monash University (AU)
  • University of Alberta (CA)
  • Universidad de Navarra (ES)
  • Inserm (FR)
  • University of Pisa (IT)
  • Amsterdam University Medical Centers (NL)
  • Capital Medical University (CN)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Nottingham (GB)
  • Baylor College of Medicine (US)
  • Peking Union Medical College Hospital (CN)
  • University of Verona (IT)
  • University of Trieste (IT)
Venue
Obesity Facts
Publisher
S. Karger AG
Published
2022
Volume
15
Issue
3
Pages
321-335
ISSN
  • 1662-4025 (ISSN-L)
  • 1662-4033
OpenAlex
W4225632118
Cited by
1,019
References
126
Citations by year
2026: 287 · 2025: 281 · 2024: 246 · 2023: 156 · 2022: 49
FWCI
113.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Obesity Facts (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • HAL (submittedVersion, cc-by-nc)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056350)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
sarcopenic obesity, sarcopenia, obesity, diagnostic criteria, definitions, skeletal muscle mass, skeletal muscle function, body composition, excess adiposity, body mass index, waist circumference, disease staging
MeSH terms
Body Composition, Humans, Obesity, Prospective Studies, Body Mass Index, Muscle, Skeletal, Adiposity, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.